Jack W. Singer, EVP, Global Medical Affairs at CTI BIOPHARMA CORP (CTIC), sold 15,000 shares at $1.55 ($24K) on 2015-08-28, disclosed to the SEC on 2015-08-28.
Scheduled sale ($24k) by EVP, Global Medical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.55 | 300 | $465 | 2.0% |
| 2 | $1.56 | 750 | $1K | 4.9% |
| 3 | $1.57 | 50 | $79 | 0.3% |
| 4 | $1.57 | 1,700 | $3K | 11.2% |
| 5 | $1.58 | 6,200 | $10K | 41.3% |
| 6 | $1.59 | 1,200 |
| $2K |
| 8.0% |
| 7 | $1.59 | 4,200 | $7K | 28.1% |
| 8 | $1.60 | 300 | $480 | 2.0% |
| 9 | $1.60 | 200 | $320 | 1.3% |
| 10 | $1.61 | 100 | $161 | 0.7% |
| Total | $1.58 avg | 15,000 | $24K | 100% |
| Filing → |
| CTIC | SELL | 2015-12-18 | $18K | — | Filing → |
| CTIC | SELL | 2015-11-30 | $18K | — | Filing → |
| CTIC | SELL | 2015-10-23 | $24K | — | Filing → |